Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05097417

Traditional Chinese Medicine Combined With Thermal and Cold Ablation for Early-stage Lung Cancer

Non-small Cell Lung Cancer Stage I Clinical Trial

Official title:
A Prospective Open-Label Randomized Study of Traditional Chinese Medicine Combined With Thermal and Cold Ablation for Early-stage Lung Cancer

Clinical Trial Summary

Lung cancer is the leading cause of cancer related mortality. At present, surgical treatment is the main choice for early-stage lung cancer. Even after surgery, the 5-year recurrence rate is still as high as 18.4%-24%. Traditional Chinese medicine combined with thermal and cold ablation could be an alternative treatment. Small sample clinical cases verified that this therapy could be an efficacy and safe treatment in a short period. The primary aim of this trial is to evaluate the efficacy of traditional Chinese medicine combined with thermal and cold ablation for patients with stage I non-small cell lung cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05097417
Study type Interventional
Source Shanghai 10th People's Hospital
Contact Lihong Fan, M.D.
Phone +8613661599588
Email fanlih@aliyun.com
Status Recruiting
Phase N/A
Start date November 1, 2021
Completion date November 1, 2024
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05451173 - Combining ICI With SBRT or HypoFrx-RT for ES NSCLC Phase 1/Phase 2
Active, not recruiting NCT03603002 - Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer N/A
Completed NCT04342377 - The Canada Lymph Node Score Project: A Crossover Trial Phase 3
Recruiting NCT06341387 - Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer
Completed NCT01991418 - Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC) N/A
Completed NCT03216551 - Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003)
Recruiting NCT03172156 - ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS N/A
Withdrawn NCT03431415 - Surgery Versus Stereotactic Body Radiation Therapy for Stage up to IA2 (T1a or T1b) Non-small Cell Lung Cancer N/A
Recruiting NCT04716946 - Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy Phase 2
Withdrawn NCT03029871 - Oncolytic Adenovirus-Mediated Gene Therapy for Lung Cancer Phase 1
Active, not recruiting NCT06180239 - Segmentectomy vs Lobectomy
Active, not recruiting NCT03383302 - SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects Phase 1/Phase 2
Completed NCT04271384 - Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer Phase 2
Recruiting NCT02622581 - Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
Not yet recruiting NCT02011997 - Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion Phase 3
Recruiting NCT05453721 - Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane（IMPLANE-0529） N/A
Active, not recruiting NCT01795521 - LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC Phase 2
Recruiting NCT04944173 - SCION: SABR and Checkpoint Inhibition Of NSCLC Phase 2
Recruiting NCT04585477 - Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E) Phase 2